1. Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study. Issue 3 (27th May 2020) Authors: Mansour, Sam E; Kiernan, Daniel F; Roth, Daniel B; Eichenbaum, David; Holekamp, Nancy M; Kaba, Samer; Werts, Erica Journal: British journal of ophthalmology Issue: Volume 105:Issue 3(2021) Page Start: 414 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Vitrectomy After ocriplasmin for VitreOmacular adhesion Or Macular hole (VAVOOM) study. Issue 9 (9th December 2015) Authors: Greven, Margaret A; Garg, Sunir; Chiu, Bing; Shah, Sumit P; Wolfe, Jeremy; Fine, Howard F; Roth, Daniel B; Robinson, Joshua; Mong, Jacob; Hsu, Jason; Regillo, Carl; Ho, Allen; Haller, Julia A Journal: British journal of ophthalmology Issue: Volume 100:Issue 9(2016) Page Start: 1211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗